PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 186 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $14,060,000 | -31.0% | 237,710 | -20.6% | 0.08% | -31.5% |
| Q1 2018 | $20,363,000 | -29.6% | 299,243 | +0.5% | 0.11% | -30.2% |
| Q4 2017 | $28,918,000 | -44.9% | 297,620 | +34.0% | 0.16% | -47.0% |
| Q1 2015 | $52,440,000 | +23.2% | 222,100 | -1.2% | 0.30% | +22.4% |
| Q4 2014 | $42,560,000 | -60.8% | 224,869 | -50.6% | 0.24% | -21.2% |
| Q3 2014 | $108,534,000 | +245.6% | 454,940 | -4.4% | 0.31% | +82.9% |
| Q2 2014 | $31,400,000 | -7.7% | 475,768 | +45.7% | 0.17% | -9.1% |
| Q1 2014 | $34,016,000 | – | 326,639 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |